Experienced in Stroke

Shigeru Y. Saito

Maebashi, JP 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Stroke
Maebashi, JP 
OverviewLocationsClinical Research

Overview

Shigeru Saito practices in Maebashi, Japan. Mr. Saito is rated as an Experienced expert by MediFind in the treatment of Stroke. His top areas of expertise are Coronary Heart Disease, Preeclampsia, High Blood Pressure in Infants, Percutaneous Coronary Intervention (PCI), and Lithotripsy.

His clinical research consists of co-authoring 774 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles and participated in 1 clinical trial in the study of Stroke.

Gender
Male

Locations

Maebashi, 3718511, Japan
Other Locations
Sugitani, Japan
Kamakura, Japan
Toyama, Japan
3191195, Japan
Tokyo, 1848795, Japan
Okinawa, Japan
Nagahama, 5260829, Japan
Shizuoka, 4228526, Japan
Chiba, Japan
Okazaki, 4448787, Japan
Kawasaki, Japan
Yonago, Japan
Tomioka, Japan
Sapporo, Japan
Mitaka, 1818588, Japan
Matsumoto, Japan
Saitama, Japan
Tokai, 3191106, Japan
Atsugi, 2430198, Japan
Toshima, 1718501, Japan
Kyoto, 6068507, Japan
Kobe, Japan
Kiryu, 3768515, Japan
Okayama, Japan
Yokohama, Japan
Shibuya, 1500001, Japan
Honjo, 8608556, Japan
Shiojiri, Japan
Aomi, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Enrollment Status: Recruiting
Publish Date: February 27, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Enrollment Status: Completed
Publish Date: November 14, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
Multi-center Study for Evaluating the Safety and Efficacy of the MedJ-01 Ridaforolimus Eluting Coronary Stent System (MedJ-01) In Coronary Stenosis Trial
Multi-center Study for Evaluating the Safety and Efficacy of the MedJ-01 Ridaforolimus Eluting Coronary Stent System (MedJ-01) In Coronary Stenosis Trial
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Device
Study Phase: Not Applicable
AltaValve Early Feasibility Study Protocol
AltaValve Early Feasibility Study Protocol
Enrollment Status: Unknown
Publish Date: September 01, 2023
Intervention Type: Device
Study Phase: Not Applicable
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Device
Study Phase: Not Applicable
DISCO Radial Trial: DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention: a Randomized Multicenter Trial
DISCO Radial Trial: DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention: a Randomized Multicenter Trial
Enrollment Status: Completed
Publish Date: May 24, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Enrollment Status: Unknown
Publish Date: October 08, 2019
Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Replacement in the Asian Pacific Population
Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Replacement in the Asian Pacific Population
Enrollment Status: Completed
Publish Date: September 25, 2019
Intervention Type: Device
View 9 Less Clinical Trials

774 Total Publications

Protective role of soluble CD52 in obesity-associated steatotic liver disease and glucose dysregulation in mice.
Protective role of soluble CD52 in obesity-associated steatotic liver disease and glucose dysregulation in mice.
Journal: Molecular metabolism
Published: October 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Saito's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 20 Advanced Conditions
    View All 125 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile